我们如何应对：肝细胞癌的治疗选择 - Suppr

How we approach it: treatment options for hepatocellular carcinoma.

作者信息

Hernaez Ruben, El-Serag Hashem B

机构信息

Section of Gastroenterology and Hepatology, Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

出版信息

Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.

DOI:10.1038/s41395-018-0008-9

PMID:29713029

Abstract

摘要

相似文献

How we approach it: treatment options for hepatocellular carcinoma.

Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.

TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma.

J Cancer Res Ther. 2020 Sep;16(5):957-959. doi: 10.4103/jcrt.JCRT_850_20.

Hepatocellular carcinoma: status in the era of liver transplantation.

J Okla State Med Assoc. 2009 Dec;102(12):355-61.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.

Advances in Hepatocellular Carcinoma.

Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014.

Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.

Dig Liver Dis. 2009 Feb;41(2):175-6. doi: 10.1016/j.dld.2008.08.005. Epub 2008 Oct 11.

What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?

J Gastrointest Cancer. 2020 Dec;51(4):1148-1151. doi: 10.1007/s12029-020-00490-0.

Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.

Gastrointest Endosc. 2006 Apr;63(4):718-20. doi: 10.1016/j.gie.2005.10.021.

Hepatocellular carcinoma in children.

Clin Liver Dis. 2015 May;19(2):433-47. doi: 10.1016/j.cld.2015.01.010. Epub 2015 Feb 28.

Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7.

引用本文的文献

Exploring the association between chemotherapy and prognosis among patients less than 50 years old with hepatocellular carcinoma: a retrospective cohort study based on the SEER database.

Discov Oncol. 2025 May 7;16(1):682. doi: 10.1007/s12672-025-02490-7.

Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents.

Front Pharmacol. 2024 Apr 26;15:1399677. doi: 10.3389/fphar.2024.1399677. eCollection 2024.

A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma.

Theranostics. 2022 Jan 24;12(4):1769-1782. doi: 10.7150/thno.68456. eCollection 2022.

Rhenium Perrhenate (ReO) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells.

Cells. 2022 Jan 17;11(2):305. doi: 10.3390/cells11020305.

LETM1 Knockdown Promotes Autophagy and Apoptosis Through AMP-Activated Protein Kinase Phosphorylation-Mediated Beclin-1/Bcl-2 Complex Dissociation in Hepatocellular Carcinoma.

Front Oncol. 2021 Jan 21;10:606790. doi: 10.3389/fonc.2020.606790. eCollection 2020.

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.

Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival.

Cancer Med. 2019 Mar;8(3):928-938. doi: 10.1002/cam4.1948. Epub 2019 Jan 31.

Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma.

Transl Gastroenterol Hepatol. 2018 Nov 26;3:97. doi: 10.21037/tgh.2018.11.05. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

How we approach it: treatment options for hepatocellular carcinoma.

作者信息

Hernaez Ruben, El-Serag Hashem B

机构信息

出版信息

Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.

DOI:10.1038/s41395-018-0008-9

PMID:29713029

Abstract

摘要

相似文献

How we approach it: treatment options for hepatocellular carcinoma.

Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.

TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma.

J Cancer Res Ther. 2020 Sep;16(5):957-959. doi: 10.4103/jcrt.JCRT_850_20.

Hepatocellular carcinoma: status in the era of liver transplantation.

J Okla State Med Assoc. 2009 Dec;102(12):355-61.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.

Advances in Hepatocellular Carcinoma.

Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014.

Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.

Dig Liver Dis. 2009 Feb;41(2):175-6. doi: 10.1016/j.dld.2008.08.005. Epub 2008 Oct 11.

What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?

J Gastrointest Cancer. 2020 Dec;51(4):1148-1151. doi: 10.1007/s12029-020-00490-0.

Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.

Gastrointest Endosc. 2006 Apr;63(4):718-20. doi: 10.1016/j.gie.2005.10.021.

Hepatocellular carcinoma in children.

Clin Liver Dis. 2015 May;19(2):433-47. doi: 10.1016/j.cld.2015.01.010. Epub 2015 Feb 28.

Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7.

引用本文的文献

Exploring the association between chemotherapy and prognosis among patients less than 50 years old with hepatocellular carcinoma: a retrospective cohort study based on the SEER database.

Discov Oncol. 2025 May 7;16(1):682. doi: 10.1007/s12672-025-02490-7.

Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents.

Front Pharmacol. 2024 Apr 26;15:1399677. doi: 10.3389/fphar.2024.1399677. eCollection 2024.

A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma.

Theranostics. 2022 Jan 24;12(4):1769-1782. doi: 10.7150/thno.68456. eCollection 2022.

Rhenium Perrhenate (ReO) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells.

Cells. 2022 Jan 17;11(2):305. doi: 10.3390/cells11020305.

LETM1 Knockdown Promotes Autophagy and Apoptosis Through AMP-Activated Protein Kinase Phosphorylation-Mediated Beclin-1/Bcl-2 Complex Dissociation in Hepatocellular Carcinoma.

Front Oncol. 2021 Jan 21;10:606790. doi: 10.3389/fonc.2020.606790. eCollection 2020.

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.

Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival.

Cancer Med. 2019 Mar;8(3):928-938. doi: 10.1002/cam4.1948. Epub 2019 Jan 31.

Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma.

Transl Gastroenterol Hepatol. 2018 Nov 26;3:97. doi: 10.21037/tgh.2018.11.05. eCollection 2018.

How we approach it: treatment options for hepatocellular carcinoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

How we approach it: treatment options for hepatocellular carcinoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献